Scarica l'app Stockscreener
0.1458
38.43%
0.0373
Precedente Chiudi:
$0.1085
Aprire:
$0.1477
Volume 24 ore:
219.68M
Relative Volume:
7.76
Capitalizzazione di mercato:
$9.86M
Reddito:
-
Utile/perdita netta:
$-11.00M
Rapporto P/E:
-0.3684
EPS:
-0.3956
Flusso di cassa netto:
$-11.99M
1 W Prestazione:
+51.87%
1M Prestazione:
+38.56%
6M Prestazione:
-60.05%
1 anno Prestazione:
-96.59%
Intervallo 1D:
$0.1341
$0.1568
Intervallo di 1 settimana:
$0.0989
$0.1568
Portata 52W:
$0.095
$4.85
Liminatus Pharma Inc Stock (LIMN) Company Profile
Nome
Liminatus Pharma Inc
Settore
Industria
Telefono
213-273-5453
Indirizzo
12611 HIDDENCREEK WAY, CERRITOS
Compare LIMN vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
0.1468 | 7.49M | 0 | -11.00M | -11.99M | -0.3956 |
VRTX
Vertex Pharmaceuticals Inc
|
528.69 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
798.44 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
874.78 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.54 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
358.89 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Liminatus Pharma Inc Borsa (LIMN) Ultime notizie
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Liminatus Pharma moves to Nasdaq Capital Market - Investing.com
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement - The Manila Times
Liminatus Pharma Shareholders Approve Reverse Stock Split Plan - The Globe and Mail
Liminatus Pharma, Inc. Revenue Breakdown – NASDAQ:LIMN - tradingview.com
Liminatus Pharma (NASDAQ: LIMN) cites $2.5M equity in Nasdaq compliance review - Stock Titan
Liminatus Pharma, Inc. Revenue Breakdown – NASDAQ:LIMNW - TradingView
Liminatus Pharma, Inc. Revenue Breakdown – BOATS:LIMN - TradingView
Liminatus Pharma Faces Nasdaq Delisting Risk, Plans Reverse Split - TipRanks
Liminatus Pharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Liminatus Pharma, Inc. Class A Common Stock (NASDAQ: LIMN) Stock Price, News & Analysis - Kalkine
Samda Biolab discloses 5.1% Liminatus Pharma (LIMN) ownership position - Stock Titan
$Liminatus Pharma (LIMN.US)$ - Moomoo
Frontier tech research, news & data - MLQ.ai
Liminatus Pharma Warrants (LIMNW) Edge Higher: A Closer Look at the $0.06 LevelPrice Action Signals - dars.gov.et
Enterprise value to EBITDA forward of Liminatus Pharma, Inc. – BOATS:LIMNW - TradingView
Price to earnings forward of Liminatus Pharma, Inc. – BOATS:LIMNW - TradingView
Enterprise value to EBIT forward of Liminatus Pharma, Inc. – BOATS:LIMNW - TradingView
Liminatus Pharma (LIMN) - Moomoo
Curious about the most active stocks on Thursday? - ChartMill
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Liminatus Pharma (LIMN) Stock Is Trending Overnight — Here’s Why it Spiked Over 30% in After-Hours Session - Sahm
Form 13D/A Liminatus Pharma For: 14 July By Investing.com - Investing.com Nigeria
Form 4 Liminatus Pharma Inc For: 14 July By Investing.com - Investing.com Nigeria
Liminatus Pharma (LIMN) investors Valetudo and Chris Kim report 9.6M-share stake - Stock Titan
Liminatus Pharma Warrants (LIMNW) Hold Steady at $0.05 in Stagnant TradingStrong Buy Stocks - dars.gov.et
Form DEF 14A Liminatus Pharma Inc For: 13 July By Investing.com - Investing.com Nigeria
Enterprise value to EBIT forward of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Price to sales forward of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Price to sales forward of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView
Liminatus Pharma(LIMN) Stock Options Chain | Quotes & News - Moomoo
Enterprise value to EBIT forward of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView
Number of employees of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Enterprise value to EBITDA forward of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Price to earnings forward of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView
Form 4 Liminatus Pharma Inc For: 6 July By Investing.com - Investing.com Nigeria
4.37M Liminatus (NASDAQ: LIMN) shares moved in entity transfer - Stock Titan
Ewon Comfortech discloses 5.5M Liminatus Pharma (LIMN) shares - Stock Titan
Ewon Comfortech discloses 5.5M shares in Liminatus Pharma (NASDAQ: LIMN) - Stock Titan
Liminatus Pharma Closes InnocsAI Merger and Share Issuance - TipRanks
Liminatus Pharma (LIMN) completes InnocsAI acquisition with large convertible preferred stake - Stock Titan
Enterprise value to revenue forward of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView
LIMNLiminatus Pharma Inc Options - Finviz
LIMN Should I Buy - Intellectia AI
Thursday's session: most active stocks - ChartMill
Get insights into the top gainers and losers of Thursday's pre-market session. - ChartMill
Liminatus Pharma (LIMN) stock is trending overnight — here’s why it spiked over 30% in after-hours session (updated) - MSN
Liminatus Pharma (LIMN) Stock Is Trending Overnight — Here’s Why it Spiked Over 30% in After-Hours Sessio - Benzinga
Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline - The Manila Times
Liminatus amends InnocsAI merger, closing set for July 2 By Investing.com - Investing.com India
Liminatus Pharma Inc Azioni (LIMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
2.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):